LivaNova (NASDAQ:LIVN) Shares Gap Up to $48.79

LivaNova PLC (NASDAQ:LIVN) shares gapped up before the market opened on Tuesday . The stock had previously closed at $48.79, but opened at $50.37. LivaNova shares last traded at $51.38, with a volume of 59,088 shares.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. Needham & Company LLC raised their target price on LivaNova from $72.00 to $75.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Robert W. Baird upgraded shares of LivaNova from a “neutral” rating to an “outperform” rating and increased their target price for the stock from $55.00 to $66.00 in a research note on Tuesday. Finally, Stifel Nicolaus raised their price target on LivaNova from $70.00 to $72.00 and gave the company a “buy” rating in a report on Thursday, July 25th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $70.80.

LivaNova Stock Performance

The business’s 50-day moving average is $48.85 and its 200 day moving average is $53.47. The company has a market cap of $2.81 billion, a PE ratio of -85.63 and a beta of 1.00. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.94 and a current ratio of 3.45.

LivaNova (NASDAQ:LIVN) last issued its earnings results on Wednesday, July 31st. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.15. LivaNova had a positive return on equity of 13.77% and a negative net margin of 1.37%. The company had revenue of $318.60 million during the quarter, compared to analysts’ expectations of $305.05 million. On average, equities research analysts predict that LivaNova PLC will post 2.58 EPS for the current fiscal year.

Institutional Investors Weigh In On LivaNova

A number of large investors have recently added to or reduced their stakes in the company. Hexagon Capital Partners LLC lifted its stake in LivaNova by 117.8% in the second quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after acquiring an additional 370 shares during the period. Fifth Third Bancorp lifted its position in shares of LivaNova by 97.1% in the 2nd quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after purchasing an additional 332 shares during the period. Lazard Asset Management LLC purchased a new stake in shares of LivaNova in the 1st quarter worth about $84,000. Canada Pension Plan Investment Board bought a new stake in shares of LivaNova during the 2nd quarter valued at about $88,000. Finally, Acadian Asset Management LLC purchased a new position in shares of LivaNova during the first quarter valued at about $94,000. Institutional investors own 97.64% of the company’s stock.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.